Drug Markets/Tacrolimus Extended-Release Capsules

Tacrolimus Extended-Release Capsules

3 NDCs across 1 manufacturer|0 Generic,3 Brand

▸ More about this market

Tacrolimus Extended-Release Capsules is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $2.88 to $27.77 per EA — the most expensive product costs about 9.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

0G / 3B

Manufacturers

1

competing in market

Price Spread

$2.88 – $27.77

per EA

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing TACROLIMUS EXTENDED-RELEASE CAPSULES

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

How many Tacrolimus Extended-Release Capsules products are on the market?

The Tacrolimus Extended-Release Capsules drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.

What is the price range for Tacrolimus Extended-Release Capsules?

NADAC reference prices for Tacrolimus Extended-Release Capsules range from $2.8817 to $27.7722 per EA — the most expensive product costs about 9.6× the cheapest.

Which manufacturers make Tacrolimus Extended-Release Capsules?

1 manufacturer lists Tacrolimus Extended-Release Capsules in NADAC. Ranked by number of NDCs, the largest are Astellas Pharma US, Inc. (3).